RXRX Operating Expenses
Recursion Pharmaceuticals Inc Clas · Operating Expenses
RXRX Operating Expenses
Latest reported$518.41Mperiod ending
RXRX TTM Operating Expenses ($88.03M → $518.41M)
TTM operating expenses
High-resolution chart · PNG
RXRX operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 518,414,000 | |
| 562,436,000 | |
| 624,233,000 | |
| 682,722,000 | |
| 647,295,000 | |
| 577,874,000 | |
| 492,255,000 | |
| 416,443,000 | |
| 402,861,000 | |
| 380,462,000 | |
| 351,348,000 | |
| 315,493,000 | |
| 276,935,000 | |
| 253,203,000 | |
| 237,133,000 | |
| 240,775,000 | |
| 229,460,000 | |
| 213,272,000 | |
| 192,775,000 | |
| 153,447,000 | |
| 127,881,000 | |
| 102,669,000 | |
| 88,028,000 |